Welcome to our blog on precision oncology, where we delve into the cutting-edge field that is revolutionizing cancer treatment. In this digital space, we aim to explore the objective of precision oncology: to provide individualized, targeted therapies that maximize effectiveness while minimizing the side effects commonly associated with traditional treatments.

Join us as we discuss how researchers unravel the intricate web of genomic and molecular data to produce diagnostic tests and treatments. We will uncover the latest advancements, and showcase the real-life impact of precision oncology on patients’ lives. Whether you’re a healthcare professional, a patient, or simply curious about the future of cancer care, this blog is your guide to understanding the remarkable potential of precision oncology.

 
MOST RECENT
PAPILLARY THYROID CANCER
RADIOACTIVE IODONE
RADIOFREQUENCY ABLATION
TREATMENT

The Technological Drivers Powering Precision Oncology

Previously, we talked about some of the factors that will enhance the adoption of precision oncology. But at its core, precision...

Understanding Radioactive Iodine Resistance in Thyroid Cancer: Overcoming Treatment Challenges

Understanding Radioactive Iodine Resistance in Thyroid Cancer: Overcoming Treatment Challenges Radioactive iodine (RAI) therapy is a common and effective treatment...

Radioactive Iodine Therapy: A Precision Weapon against Thyroid Cancer

Radioactive Iodine Therapy: A Precision Weapon against Thyroid Cancer Radioactive iodine (RAI) is a special treatment for thyroid cancer that...

Radiofrequency Ablation: An Alternative Approach to Treating Papillary Thyroid Cancer

Radiofrequency Ablation: An Alternative Approach to Treating Papillary Thyroid Cancer Papillary thyroid cancer (PTC) is the most common type of...

Surgical Approaches to Thyroid Cancer

Surgical Approaches to Thyroid Cancer Thyroid cancer, a complex disease affecting the thyroid gland, often requires surgical intervention as a...

Anaplastic Thyroid Cancer: A Rare but Aggressive Thyroid Malignancy

Anaplastic Thyroid Cancer: A Rare but Aggressive Thyroid Malignancy Thyroid cancer has different types, and one of the most aggressive...

Prognostication with Thyroid GuidePx in the context of tall cell variants

The tall cell variant of papillary thyroid cancer generally has a worse prognosis compared with the classical variant. Thyroid GuidePx is a genomic classifier capable of classifying papillary thyroid cancer into 3 molecular subtypes using fine-needle aspirate. Type 1 and 2 have low recurrence rates, particularly in early tumors (1–4 cm and N0). Type 3 is characterized by aggressive biology and high recurrence rates regardless of size and lymph node status. The study examines the interaction of tall cell variant histology with Thyroid GuidePx risk stratification.

Read More »
October 28, 2024